All tuberculosis articles – Page 4
-
NewsCattle may face much higher TB risk from indirect interactions with wildlife
Cattle face a hypothetically high risk of getting tuberculosis from wildlife - such as deer, foxes, and wild boar - through indirect interactions, with a much lower risk from direct interactions, a new study suggests.
-
NewsNew VDEC is ‘step change’ for UK’s growing vaccine capabilities
The UK Health Security Agency has unveiled its world-leading Vaccine Development and Evaluation Centre at Porton Down, which will be at the forefront of the UK’s ability to develop vaccines against the world’s deadliest pathogens.
-
NewsStudy demonstrates efficacy of new short-term resistant TB treatment
Four patients at Boston Medical Center (BMC) Tuberculosis Clinic were cured of MDR TB with a six-month regimen that included bedaquiline, pretomanid and linezolid (BPaL).
-
NewsInvestigational three-month TB regimen is safe but ineffective
The first clinical trial of a three-month tuberculosis (TB) treatment regimen is closing enrollment because of a high rate of unfavorable outcomes with the investigational course of treatment.
-
NewsNearly half of TB cases in prisons worldwide go undetected
In the first global assessment of tuberculosis among incarcerated people, a new study found consistently high TB case rates and low case detection in prisons.
-
NewsConsortium awarded €9M to create better tuberculosis vaccine
Researchers from the University of Leicester are among those hoping to create an improved vaccine to fight tuberculosis as part of a €9 million Euro project.
-
NewsBCG vaccine found ineffective against COVID-19 in healthcare workers
An international trial investigating the potential immune-boosting effects of the tuberculosis BCG vaccine against COVID-19 found that the risk of developing the disease during the first six months after vaccination was not reduced in participants as originally hoped for.
-
NewsBCG does not protect health workers against Covid
A world-leading international trial into the immune boosting benefits of the tuberculosis vaccine, BCG, has found it does not protect healthcare workers against COVID-19.
-
NewsInternational consensus highlights importance of molecular testing for AMR in TB management
A multidisciplinary group of tuberculosis experts from the TBnet and RESIST-TB networks have reached a consensus on key issues related to the molecular prediction of Mycobacterium tuberculosis antibiotic sensitivity or resistance and its clinical implications.
-
NewsScientists use non-virulent strain to expose weaknesses in drug-resistant TB
Researchers have discovered new ways to treat antibiotic-resistant strains of tuberculosis (TB), opening the door to new approaches for tackling the disease that kills about 4,000 people a day.
-
NewsWar in Ukraine pushes highly contagious infectious diseases to alarming levels
New research being presented at this year’s ECCMID reveals an extremely worrying picture of rising infectious disease cases and falling levels of childhood vaccination and case detection in Kharkiv, the scene of some of the most intense combat in 2022.
-
NewsEurope set to miss 2030 SDG target for ending TB as global threat
A new paper examining progress towards the Sustainable Development Goals target for tuberculosis and associated targets warns that as it stands, the EU/EEA will not reach the set targets by 2030.
-
NewsFDA-approved TB regimen may not work against deadliest form of TB
Investigators say their research indicates a new combination of drugs is needed to find an effective treatment for TB meningitis due to multidrug-resistant (MDR) strains.
-
NewsIron-scavenging endophyte could be newest weapon against resistant TB
An iron-scavenging endophytic bacterium could be the latest class of weapon in the fight against multi-drug resistant tuberculosis, researchers have found.
-
NewsNew £1.7m containment facility will help prepare for future pandemics
A £1.7m laboratory building which will investigate infectious diseases has opened at the University of Warwick – helping to tackle some of the most globally important human diseases and prepare for pandemics of the future.
-
NewsScientists reveal protein mechanism behind tuberculosis pathogen success
A group of Chinese scientists has uncovered a previously undefined pathway by which Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), counteracts host immunity.
- Previous Page
- Page1
- Page2
- Page3
- Page4
- Next Page
